WallStreetZenWallStreetZen

NASDAQ: ATYR
Atyr Pharma Inc Stock Ownership - Who owns Atyr Pharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Atyr Pharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jill Marie BroadfootChief Financial Officer2026-02-041,558$0.98
$1.52kSell
Nancy DenyesGeneral Counsel2026-02-041,118$0.98
$1.09kSell
Sanjay ShuklaPresident and CEO2026-02-043,745$0.98
$3.66kSell
Paul SchimmelDirector2025-10-09317,999$0.94
$299.24kBuy
Paul SchimmelDirector2025-10-08682,001$0.90
$612.44kBuy
Jane A. GrossDirector2025-03-173,750$4.00
$15.00kBuy

1 of 1

ATYR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ATYR insiders and whales buy or sell their stock.

ATYR Shareholders

What type of owners hold Atyr Pharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC14.99%14,697,995$13.55MInstitution
Federated Hermes Inc10.72%10,509,678$9.69MInstitution
Blackrock Inc6.68%6,549,699$6.04MInstitution
Vanguard Group Inc5.06%4,961,871$4.57MInstitution
Gsa Capital Partners LLP2.68%2,630,638$2.43MInstitution
Geode Capital Management LLC2.33%2,283,717$2.11MInstitution
Sofinnova Venture Partners IX LP1.90%1,866,126$1.72MInsider
Srinivas Akkaraju1.90%1,866,126$1.72MInsider
Amir Nashat1.88%1,840,564$1.70MInsider
Polaris Venture Management Co V LLC1.86%1,827,992$1.69MInsider

1 of 3

ATYR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ATYR55.92%15.71%Net BuyingNet Selling
PMVP58.91%41.09%Net Selling
IBIO32.11%67.89%
PLRX64.06%35.94%Net SellingNet Selling
SPRB3.96%96.04%Net SellingNet Buying
View Top Biotech Stocks

Atyr Pharma Stock Ownership FAQ

Who owns Atyr Pharma?

Atyr Pharma (NASDAQ: ATYR) is owned by 55.92% institutional shareholders, 15.71% Atyr Pharma insiders, and 28.38% retail investors. Sofinnova Venture Partners IX LP is the largest individual Atyr Pharma shareholder, owning 1.87M shares representing 1.90% of the company. Sofinnova Venture Partners IX LP's Atyr Pharma shares are currently valued at $1.62M.

If you're new to stock investing, here's how to buy Atyr Pharma stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.